Ultrasensitive Molecular Amplification Market is projected to reach US$ 31.2 Bn by 2035, driven by rising chronic disease ...

In this edition of the biotech bi-weekly, we highlight the latest exciting product launches, partnerships and company events.

The point-of-care (POC) molecular diagnostics market is steadily expanding, with a compound annual growth rate (CAGR) of approximately 6%. This growth is fueled by a growing need for fast, ...

Discusses New Strategy and Business Plan Focused on Commercialization and Liquid Biopsy Innovation November 26, 2025 9:00 ...

Explore trends before investing – request a sample report today! The Non-NGS Predictive Cancer Diagnostics Market is ...

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the ...

The "IVD Raw Materials - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for IVD Raw Materials was valued at US$27.7 Billion in 2024 and is ...

The global liquid biopsy market, poised for significant growth, benefits from increased demand for non-invasive cancer ...

The North American Nucleic Acid Amplification Testing (NAAT) market will reach $7.64 billion by 2033, growing from $3.28 ...

Cell free RNA diagnostics market is projected to reach US$ 204.5 Mn by 2035, expanding at a CAGR of 14.5% from 2025 to 2035 ...